Building a Biopharma Company
The innovative spirit of biotech startups is a driving force behind the development of new therapeutic products, but building a successful biopharmaceutical company from the ground up has its risks and challenges.
The Evolving Role of Starting Materials in Cell and Gene Therapy
Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting materials, and they must ensure a steady supply.
Fighting the Good Fight
Nearly four decades after the first diagnosis, the fight to treat HIV/AIDs continues.
Prevent, Detect, and Remove: Viral Control for Viral Vectors
Ensuring that viral vectors are free of viral contaminants requires a focus on prevention and control.
Investigating Combination Product Failures
Investigating deviations or failures of combination products needs to accommodate both the drug and device components, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished
Quality Issues Offset Biomedical Advances
Problems in assuring reliable drug quality and supply dampens progress in bringing lifesaving therapies to market.
Antibody Purification Process Development and Manufacturing
Downstream process development and manufacturing play a crucial role to ensure safety, quality, identity, purity, and efficacy.
BioPharm International, December 2019 Issue (PDF)
Click the title above to open the BioPharm International December 2019 issue in an interactive PDF format.
